Trial Profile
Comparative Low and High Dose of Dexmedethomidine Can Stabilize Hemodynamics and Blood Loss in Pituitary Tumor Removal by Transphenoid Approach
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 03 May 2019
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Hypertension; Surgical blood loss; Tachycardia
- Focus Therapeutic Use
- 25 May 2017 Planned End Date changed from 1 Jun 2017 to 1 Jun 2018.
- 02 May 2017 New trial record